Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hims and Hers Health Inc (HIMS) vs Paychex, Inc. (PAYX) Price & Performance

Hims and Hers Health IncTrade
Paychex, Inc.Trade

Price performance (Past 24H)

Key statistics

Hims and Hers Health Inc vs Paychex, Inc. — how do they compare? Hims and Hers Health Inc trades at $32.91 (market cap $7.57B), while Paychex, Inc. trades at $113.66 (market cap $40.98B). The key difference: Paychex, Inc. is far larger — about 5.4× Hims and Hers Health Inc's market cap, and Paychex, Inc. pays a 4.13% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.

HIMSPAYX
Market Cap
$7.57B$40.98B
Sector
HealthIndustrials
52-Week High
$66.18$147.99
52-Week Low
$14.52$85.57
Enterprise Value
$7.95B$44.47B
Dividend Yield
4.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hims and Hers Health Inc

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

Paychex, Inc.

Paychex (PAYX) trades at $115.15, up 0.66% today, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.32 beating expectations of $1.31, and maintains high profitability with a 27.03% net income margin. Recent developments include dividend declarations and positive small business job growth trends.

Outlook remains positive with steady revenue growth and AI expansion driving future performance, though valuation metrics appear elevated with P/E at 23.39. Key risks include macroeconomic sensitivity to small business hiring and competitive pressures. Analyst consensus is mixed with 63.33% hold ratings and a $110 price target slightly below current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS

About Paychex, Inc.

Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.

Read more on PAYX